Please provide your email address to receive an email when new articles are posted on . Ajovy offers “significant efficacy” compared with placebo to address episodic migraine in children and ...
Aug 5 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Ajovy, an injection made by Israeli drugmaker Teva Pharma (TEVA.TA), opens new tab, to help prevent migraines in children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback